Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Techniques & Tools

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma & Biopharma
    • Omics
    • Forensics
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Power List / 2017

The Power List 2017

With two somewhat provocative Power Lists behind us, we once again forge ahead with our mission to celebrate 100 fantastic individuals involved in bettering the pharma industry and bringing life-changing medicines to market.

Welcome to the 2017 Power List, where we’ve divided our Top 100 into four categories, each made up of 25 outstanding professionals – and each with its own Top Ten:

Masters of the Bench – scientists and researchers whose late-night lab work lays the foundations for new therapeutics.
Industry influencers – individuals who drive industry best practices and regulations, as well as new manufacturing techniques and technologies.
Business Captains – leaders and entrepreneurs who turn scientific ideas into marketable medicines.
Champions of Change – patrons of the industry who are striving to make the world a better place by getting medicines to those who need them the most.

Masters of the Bench

Robert Samuel Langer
Robert Samuel Langer

Institute Professor, Massachusetts Institute of Technology

Carl June
Carl June

Richard W. Vague Professor in Immunotherapy, University of Pennsylvania

Phil S. Baran
Phil S. Baran

Darlene Shiley Professor, The Scripps Research Institute

David Baltimore
David Baltimore

President Emeritus and Robert Andrews Millikan Professor of Biology, California Institute of Technology

Nicholas A. Peppas
Nicholas A. Peppas

Nicholas A. Peppas Professor and Director of the Institute for Biomaterials, Drug Delivery and Regenerative Medicine, The University of Texas at Austin

Shinya Yamanaka
Shinya Yamanaka

Director and Professor, Center for iPS Cell Research and Application (CiRA), Kyoto University

Joseph Schlessinger
Joseph Schlessinger

William H. Prusoff Professor and Chairman of the Pharmacology Department, Yale School of Medicine; Director, Yale Cancer Biology Institute

Christopher J. H. Porter
Christopher J. H. Porter

Professor, Monash Institute of Pharmaceutical Sciences, Monash University

Suzanne Farid
Suzanne Farid

Professor of Bioprocess Systems Engineering, University College London

Chas Bountra

Professor of Translational Medicine, Director of Structural Genomics Consortium; Director of Oxford Martin School, University of Oxford

David Bentley
David Bentley

Vice President and Chief Scientist, Illumina

Jonathan Bones
Jonathan Bones

Principal Investigator, NIBRT Characterization and Comparability Laboratory, NIBRT – The National Institute for Bioprocessing Research and Training

Jonas Bostrom
Jonas Bostrom

Principal Scientist, AstraZeneca

Meindert Danhof
Meindert Danhof

Professor of Pharmacology, Leiden University

Kenneth Getz
Kenneth Getz

Associate Professor and Director, Center for the Study of Drug Development, Tufts University School of Medicine; Founder and Board Chair, CISCRP

Helen H. Hobbs
Helen H. Hobbs

Professor, Internal Medicine and Molecular Genetics, and Director, Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center

Aaron Kesselheim
Aaron Kesselheim

Associate Professor, Medicine, Harvard Medical School; Director, Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital

Claus-Michael Lehr
Claus-Michael Lehr

Head, Department of Drug Delivery, Helmholtz-Institute for Pharmaceutical Research Saarland, Helmholtz Center for Infection Research (HZI), Saarland University

Pauline Rudd
Pauline Rudd

Principal Investigator, NIBRT – The National Institute for Bioprocessing Research and Training, Ireland

Dolores Schendel
Dolores Schendel

CEO and Chief Scientific Officer, Medigene AG

Peter Seeberger
Peter Seeberger

Director, Max-Planck-Institute of Colloids and Interfaces, and Professor, Free University of Berlin

Andreas Seidel-Morgenstern
Andreas Seidel-Morgenstern

Director, Department of Physical and Chemical Foundation of Process Engineering, Max Planck Institute for Dynamics of Complex Technical Systems

Michael Sofia
Michael Sofia

Chief Scientific Officer, Arbutus Biopharma

John Talley
John Talley

Chief Scientific Officer, Euclises Pharmaceuticals

Harold Varmus
Harold Varmus

Lewis Thomas University Professor, Weill Cornell Medical College

Industry Influencers

Richard M. Johnson
Richard M. Johnson

President and Chief Executive Officer, Parenteral Drug Association

Martin VanTrieste
Martin VanTrieste

Chairman of the Board, Parenteral Drug Association (PDA)

Andrew D. Skibo
Andrew D. Skibo

Head of Global Biologics Operations & Global Engineering, AstraZeneca/MedImmune

Moncef Slaoui
Moncef Slaoui

Former Chairman of Vaccines, GlaxoSmithKline

Guido Rasi
Guido Rasi

Executive Director, European Medicines Agency

Gil Roth
Gil Roth

President, Pharma & Biopharma Outsourcing Association

John E. Bournas
John E. Bournas

President and Chief Executive Officer, International Society for Pharmaceutical Engineering (ISPE)

Maik Jornitz
Maik Jornitz

Chief Executive Officer, G-CON Manufacturing Inc

Sir Andrew Witty
Sir Andrew Witty

Former CEO of GlaxoSmithKline; Chancellor, University of Nottingham

Rino Rappuoli
Rino Rappuoli

Chief Scientist and Head of External R&D, GSK Vaccines

James Agalloco
James Agalloco

President, Agalloco & Associates

John Aunins
John Aunins

Executive Vice President of Bioprocess & Manufacturing and Chief Technology Officer, Seres Therapeutics

Jim Breen
Jim Breen

Vice President, Lead Biologic Expansion, Johnson & Johnson

Carsten Brockmeyer
Carsten Brockmeyer

Chief Executive Officer, Formycon AG

Stephen T. Colgan
Stephen T. Colgan

Senior Director, Pfizer Worldwide Research and Development

Fiona Greer
Fiona Greer

Global Director, BioPharma Services Development, SGS

Ajaz S. Hussain
Ajaz S. Hussain

President, National Institute for Pharmaceutical Technology & Education, Inc., and Founder, Advice & Solutions LLC

Roman Ivanov
Roman Ivanov

Vice-president R&D, International business development, BIOCAD

John Lambert
John Lambert

Executive Vice President Emeritus & Distinguished Research Fellow, Immunogen

Jim Miller
Jim Miller

Founder & President, PharmSource

Niclas Nilsson
Niclas Nilsson

Head of R&D Open Innovation, LEO Pharma

Daniel O’Connor
Daniel O’Connor

Expert Medical Assessor, UK Medicines and Healthcare products Regulatory Agency

Diane Paskiet
Diane Paskiet

Director of Scientific Affairs, West Pharmaceutical Services

Cornell Stamoran
Cornell Stamoran

Vice President of Corporate Strategy, Catalent Pharma Solutions

Bernhardt L. Trout
Bernhardt L. Trout

Raymond F. Baddour, ScD, (1949) Professor of Chemical Engineering, Massachusetts Institute of Technology

Business Captains

Joseph Jimenez
Joseph Jimenez

Chief Executive Officer, Novartis

SeungSuh (Stanley) Hong
SeungSuh (Stanley) Hong

Senior Advisor, Celltrion Healthcare Co. Ltd

Kiran Mazumdar-Shaw
Kiran Mazumdar-Shaw

Chairperson and Managing Director, Biocon

Belén Garijo
Belén Garijo

Chief Executive Officer, Healthcare, Merck KGaA

Severin Schwan
Severin Schwan

Chief Executive Officer, Roche Group

Jean-Paul Clozel
Jean-Paul Clozel

Founder and Chief Executive Officer, Actelion

Raman Singh
Raman Singh

President, Mundipharma Asia Pacific, Latin America, Middle East and Africa

Heather Bresch
Heather Bresch

Chief Executive Officer and Executive Director, Mylan

John C. Martin
John C. Martin

Executive Chairman, Gilead Sciences

Manish Soman
Manish Soman

President and Chief Executive Officer, Sciformix

Stephane Bancel
Stephane Bancel

Chief Executive Officer, Moderna Therapeutics

Stéphane Boissel
Stéphane Boissel

Chief Executive Officer, TxCell

Robert A. Bradway
Robert A. Bradway

Chairman and Chief Executive Officer, Amgen

Olivier Brandicourt
Olivier Brandicourt

Chief Executive Officer, Sanofi

John Chiminski
John Chiminski

President and Chief Executive Officer, Catalent

Joaquin Duato
Joaquin Duato

Executive Vice President and Worldwide Chairman, Pharmaceuticals, Johnson and Johnson

Jane Griffiths
Jane Griffiths

Company Group Chairman, Janssen, Europe, Middle East & Africa (EMEA)

James C. Mullen
James C. Mullen

Chief Executive Officer, Patheon

Rodger Novak
Rodger Novak

Chief Executive Officer and Founder, CRISPR Therapeutics

G. V. Prasad
G. V. Prasad

Co-Chairman and Chief Executive Officer, Dr Reddy's Laboratories

Rafaat Rahmani
Rafaat Rahmani

Founder and President, Lifescience Dynamics

Ian C. Read
Ian C. Read

Chairman of the Board and Chief Executive Officer, Pfizer

Pascal Soriot
Pascal Soriot

Executive Director and Chief Executive Officer, AstraZeneca

Abbe Steel
Abbe Steel

Chief Executive Officer, HealthiVibe

Martin Tolar
Martin Tolar

Founder, President and Chief Executive Officer, Alzheon

Champions of Change

Susan Desmond-Hellmann
Susan Desmond-Hellmann

Chief Executive Officer, Bill & Melinda Gates Foundation

John Craig Venter
John Craig Venter

Founder, Chairman and Chief Executive Officer, J. Craig Venter Institute

Anthony S. Fauci
Anthony S. Fauci

Director, US National Institute of Allergy and Infectious Diseases (NIAID)

Robin Robinson
Robin Robinson

Retired

Steve Davis
Steve Davis

President and Chief Executive Officer, PATH; Lecturer on Social Innovation, Stanford Graduate School of Business

Ségolène Aymé
Ségolène Aymé

Emeritus Director of Research, French Institute of Health and Medical Research (INSERM)

Catherine Tuleu
Catherine Tuleu

Reader, University College London School of Pharmacy

Dalvir Gill
Dalvir Gill

Chief Executive Officer and Member of the Board of Directors, TransCelerate BioPharma

Elisa Cascade
Elisa Cascade

President of Data Solutions, DrugDev

Sir Andrew Dillon
Sir Andrew Dillon

Chief Executive, UK National Institute for Health and Care Excellence (NICE)

Catherine Bollard
Catherine Bollard

President, International Society of Cellular Therapy, and Professor of Paediatrics, Children’s National Medical Centre Passion

Thomas Cech
Thomas Cech

Distinguished Professor, University of Colorado Boulder

Francis S. Collins
Francis S. Collins

Director, US National Institutes of Health

Leroy (Lee) Cronin
Leroy (Lee) Cronin

Regius Chair of Chemistry, University of Glasgow

Julie Louise Gerberding
Julie Louise Gerberding

Executive Vice President & Chief Patient Officer, Strategic Communications, Global Public Policy, & Population Health, Merck Sharp & Dohme

Ben Goldacre
Ben Goldacre

Founder, AllTrails; Senior Clinical Research Fellow, Nuffield Department of Primary Care Health Sciences

Andrew Lees
Andrew Lees

Founder and Scientific Director, Fina Biosolutions LLC; Associate Professor of Medicine, University of Maryland School of Medicine, Center for Vaccine Development

Edison T. Liu
Edison T. Liu

President and Chief Executive Officer, The Jackson Laboratory

Brian Overstreet
Brian Overstreet

Co-Founder and President, Advera Health Analytics

Mark Paxton
Mark Paxton

Chief Executive Officer, Rx-360

Mike Rea
Mike Rea

Chief Executive Officer, IDEA Pharma

Tomasz Sablinski
Tomasz Sablinski

Chief Executive Officer and Co-founder, Transparency Life Sciences

Ros Smyth
Ros Smyth

Director, UCL Great Ormond Street Institute of Child Health

Matthew Todd
Matthew Todd

Associate Professor, The University of Sydney, Australia; Founder, Open Source Malaria

Stephen J Ubl
Stephen J Ubl

President and Chief Executive Officer, PhRMA

False

Advertisement

Recommended

False

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.